RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation - Wikidata - awgldk - TriplyDB

RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation

RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation

http://www.wikidata.org/entity/Q35832188

about

Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy Cancer therapy in the necroptosis era Cancer's Achilles' Heel: Apoptosis and Necroptosis to the Rescue Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes.Necroptosis: an alternative cell death program defending against cancer.Prediction of the efficacy of immunotherapy by measuring the integrity of cell-free DNA in plasma in colorectal cancer.Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy.Cancer and necroptosis: friend or foe?Necroptosis: A Novel Cell Death Modality and Its Potential Relevance for Critical Care Medicine.RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.Relevance of necroptosis in cancer.Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells.Necroptosis in cancer: An angel or a demon?Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.RIPK3-a predictive marker for personalized immunotherapy?Necroptotic cell death in anti-cancer therapy.Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies.Molecular Cell Biology of Apoptosis and Necroptosis in Cancer.Diabetes-associated dysregulated cytokines and cancer.

P2860

Q26739959-6E3200E5-274B-45AA-AC94-4AC176FFE63B Q26766339-D750D7E9-7BDF-4FAC-AB6E-23C1878FC182 Q28066868-765EE15A-B3DB-4B2D-BD23-2398AA6305E2 Q33825575-2E7C32D2-36BA-4B6B-BCCA-B559F48A79EA Q36880241-3F5681B7-AC3F-46C7-A45F-E82754178AF3 Q37544605-6EFD2CF9-5735-48D0-8316-2F3C56AFC711 Q38644639-FB2FC2DF-9E12-4D4C-AA1B-61A3F0E70305 Q38799139-475C8711-7357-4FAD-847A-A68E6CC73294 Q38861198-B81EB9C9-3285-464B-A119-8A90B8B0C6B3 Q38984566-90D35366-D895-4B37-AC11-2E6669A183D4 Q39030578-7BFB715A-3BE3-4986-A65D-B469E0E15B20 Q39105381-C9E62565-C95C-4C22-8DA7-ED62A7D62BCF Q39214221-91D8B719-1306-4C79-B7D8-D044F48DBDA3 Q39398933-56A45117-3B17-4416-A024-438B828544FC Q40045752-A3A9C3AB-8731-4768-A763-6402E352F9FC Q40437234-FA400597-7A24-4415-BEE7-4FF2DFBBBA0C Q47659073-68E766E8-FC06-44CF-B259-2727B5EB17BC Q49679681-DFB4D561-D939-46D9-9E56-462F681733C3 Q50221065-12FD4CD4-CC72-40BD-86CF-A66DA93F380E Q55331908-0171BA8C-15BB-44DF-89BD-9805328B4450

P2860

RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation

http://www.wikidata.org/entity/Q35832188

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

RIPK3 expression in cervical c ...... rine dendritic cell activation

@ast

RIPK3 expression in cervical c ...... rine dendritic cell activation

@en

type

label

RIPK3 expression in cervical c ...... rine dendritic cell activation

@ast

RIPK3 expression in cervical c ...... rine dendritic cell activation

@en

prefLabel

RIPK3 expression in cervical c ...... rine dendritic cell activation

@ast

RIPK3 expression in cervical c ...... rine dendritic cell activation

@en

P1433

Q35832188-69E6C845-BBDB-47B2-A326-25AB626C06E0

P1476

Q35832188-6830483D-7F0E-4E6B-8F1B-2E8DD3834252

P2093

Q35832188-17048D16-71D1-4933-A4D5-803DD0118591

Q35832188-2816EF55-031E-4B46-8ED6-728DFF40B679

Q35832188-2FE9C7F0-B329-49FA-A4C4-2BD0EC282D46

Q35832188-763E5593-54C9-4C43-8A98-6BEBD28F28EF

Q35832188-7A88AA19-5BA0-4680-B26B-82D2F2E1F72A

Q35832188-7FAD2A19-12C7-4FE6-BDF6-186E827F9E89

Q35832188-8847D5FC-C8B3-4AC6-B1CC-C4AEBC3C7484

Q35832188-A0D5FE90-9692-46ED-9110-9B59BE752FD9

Q35832188-A3B9B704-0152-43A8-BBFF-541ECA5BBC4E

P2860

Q35832188-00EEADA9-E673-44B2-AFFF-EB1F2BE7B05C

Q35832188-12CB62DB-E1F6-412B-A38B-FE00C42DE96C

Q35832188-1841FCA0-B1D6-412A-A36B-CF770AE30AB7

Q35832188-20EFE01F-DE8A-4E46-A842-FA04A341DCAA

Q35832188-23F18D66-453E-45A4-ABB8-CAA0B3BE3068

Q35832188-25604FDF-1A2C-44B7-8EE9-A63B0CE9BB4A

Q35832188-2DD1426B-D4C0-49DA-943E-296BD87263F5

Q35832188-2F48AD25-0018-4CB2-8911-EDE7AE6A2984

Q35832188-2F632B34-9368-47FB-939A-8153FA2BF11B

Q35832188-322F1E00-935C-49C3-A5C9-ADE3D4240A6A

P304

Q35832188-3212A09B-93E6-467C-B7C2-31F57F33EA84

P31

Q35832188-21988DF4-F2A2-4090-B20A-E4A597E90F11

P356

Q35832188-92A17F5F-2034-4A73-96E3-C94FAD9ED9D1

P407

Q35832188-618FF8E1-8A58-456F-995B-235983F97751

P433

Q35832188-0D8AAC7B-D26A-4F70-91C5-CB0FF47B1752

P478

Q35832188-196DA7EC-3BE3-42E3-9886-9ED2289AFAFC

P50

Q35832188-06B862C7-E65C-4831-B83E-81ADBF11BBA6

P577

Q35832188-6626E695-B710-4AC9-A4E5-51484FF31756

P5875

Q35832188-A2FA53E9-DDEA-467E-AFEB-92C06E632D1A

P698

Q35832188-25E47506-1960-4EC6-9127-D2F3C3F189BD

P921

Q35832188-CD46655F-ACF1-41FC-A255-254AAAE785B3

P932

Q35832188-51BA0941-C758-4342-A47B-6E31FFC13FE3

P356

ONCOTARGET.3249

P1433

P1476

RIPK3 expression in cervical c ...... rine dendritic cell activation

@en

P2093

Barbara Walch-Rückheim

http://www.w3.org/2001/XMLSchema#string

Benjamin Vicinus

http://www.w3.org/2001/XMLSchema#string

Eva-Maria Kamionka

http://www.w3.org/2001/XMLSchema#string

Jennifer Pahne-Zeppenfeld

http://www.w3.org/2001/XMLSchema#string

Rainer M Bohle

http://www.w3.org/2001/XMLSchema#string

Sigrun Smola

http://www.w3.org/2001/XMLSchema#string

Stefanie Seibert

http://www.w3.org/2001/XMLSchema#string

Susanne V Schmidt

http://www.w3.org/2001/XMLSchema#string

Yoo-Jin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase

Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Many stimuli pull the necrotic trigger, an overview

Therapy of human papillomavirus-related disease

Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis

Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis

P304

8635-8647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3249

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Erich-Franz Solomayer

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275101790

http://www.w3.org/2001/XMLSchema#string

P698

25888634

http://www.w3.org/2001/XMLSchema#string

P921

P932

4496172

http://www.w3.org/2001/XMLSchema#string